abstract |
Provided are CRISPR/CAS-related methods, compositions and components for nediting a target nucleic acid sequence, or modulating expression of a target nucleic acid nsequence, and applications thereof in connection with cancer immunotherapy comprising nadoptive transfer of engineered T cells or T cell precursors. |